These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 29730948

  • 1. Piperacillin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis.
    Kanji S, Roberts JA, Xie J, Alobaid A, Zelenitsky S, Hiremath S, Zhang G, Watpool I, Porteous R, Patel R.
    Ann Pharmacother; 2018 Oct; 52(10):965-973. PubMed ID: 29730948
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of piperacillin in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration.
    Sinnollareddy MG, Roberts MS, Lipman J, Peake SL, Roberts JA.
    J Antimicrob Chemother; 2018 Jun 01; 73(6):1647-1650. PubMed ID: 29506150
    [Abstract] [Full Text] [Related]

  • 3. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion.
    Esteve-Pitarch E, Padullés-Zamora A, Maisterra-Santos K, Colom-Codina H, Cobo-Sacristán S.
    Farm Hosp; 2019 Sep 01; 43(5):151-157. PubMed ID: 31469627
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF).
    Donnellan S, Wright DFB, Roberts JA, Duffull SB, Schollum JBW, Putt TL, Wallis SC, Walker RJ.
    Eur J Clin Pharmacol; 2020 Feb 01; 76(2):239-247. PubMed ID: 31814045
    [Abstract] [Full Text] [Related]

  • 8. Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?
    Udy AA, Lipman J, Jarrett P, Klein K, Wallis SC, Patel K, Kirkpatrick CM, Kruger PS, Paterson DL, Roberts MS, Roberts JA.
    Crit Care; 2015 Jan 30; 19(1):28. PubMed ID: 25632974
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis.
    Asín-Prieto E, Rodríguez-Gascón A, Trocóniz IF, Soraluce A, Maynar J, Sánchez-Izquierdo JÁ, Isla A.
    J Antimicrob Chemother; 2014 Jan 30; 69(1):180-9. PubMed ID: 23908259
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic analysis of piperacillin administered with tazobactam in critically ill, morbidly obese surgical patients.
    Sturm AW, Allen N, Rafferty KD, Fish DN, Toschlog E, Newell M, Waibel B.
    Pharmacotherapy; 2014 Jan 30; 34(1):28-35. PubMed ID: 23864417
    [Abstract] [Full Text] [Related]

  • 11. Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children.
    Nichols K, Chung EK, Knoderer CA, Buenger LE, Healy DP, Dees J, Crumby AS, Kays MB.
    Antimicrob Agents Chemother; 2016 Jan 30; 60(1):522-31. PubMed ID: 26552978
    [Abstract] [Full Text] [Related]

  • 12. Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis.
    Kanji S, Roberts JA, Xie J, Zelenitsky S, Hiremath S, Zhang G, Watpool I, Porteous R, Patel R.
    Clin Pharmacokinet; 2020 Mar 30; 59(3):327-334. PubMed ID: 31471789
    [Abstract] [Full Text] [Related]

  • 13. Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients.
    Dhaese SAM, Roberts JA, Carlier M, Verstraete AG, Stove V, De Waele JJ.
    Int J Antimicrob Agents; 2018 Apr 30; 51(4):594-600. PubMed ID: 29277531
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.
    Shotwell MS, Nesbitt R, Madonia PN, Gould ER, Connor MJ, Salem C, Aduroja OA, Amde M, Groszek JJ, Wei P, Taylor ME, Tolwani AJ, Fissell WH.
    Clin J Am Soc Nephrol; 2016 Aug 08; 11(8):1377-1383. PubMed ID: 27197907
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy.
    Awissi DK, Beauchamp A, Hébert E, Lavigne V, Munoz DL, Lebrun G, Savoie M, Fagnan M, Amyot J, Tétreault N, Robitaille R, Varin F, Lavallée C, Pichette V, Leblanc M.
    Pharmacotherapy; 2015 Jun 08; 35(6):600-7. PubMed ID: 26095008
    [Abstract] [Full Text] [Related]

  • 19. Piperacillin-tazobactam dosing in anuric acute kidney injury patients receiving continuous renal replacement therapy.
    Rungkitwattanakul D, Charoensareerat T, Chaichoke E, Rakamthong T, Srisang P, Pattharachayakul S, Srisawat N, Chaijamorn W.
    Semin Dial; 2023 Jun 08; 36(6):468-476. PubMed ID: 36807546
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetics of piperacillin in plasma and subcutaneous tissue in patients on continuous renal replacement therapy.
    Bue M, Sou T, Okkels ASL, Hanberg P, Thorsted A, Friberg LE, Andersson TL, Öbrink-Hansen K, Christensen S.
    Int J Infect Dis; 2020 Mar 08; 92():133-140. PubMed ID: 31978581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.